Veerhealth Care Ltd — Updates, 25-07-2025: Company Update
25-07-2025 | 11:15 am
25-07-2025 | 11:15 am
Veerhealth Care has received regulatory approval from the Food and Drug Authority, Gujarat, to manufacture personal care products. This enables their first commercial trial order, valued at approximately ₹0.48 Cr, from a leading Indian marketplace company. The order, focused on skin and face care, is a result of a strategic contract manufacturing agreement. This milestone significantly boosts Veerhealth Care's market standing and visibility, with management anticipating repeat orders and expanded product lines, marking a crucial step in their growth trajectory.
No comments yet. Be the first to comment!
